메뉴 건너뛰기




Volumn 18, Issue 7, 2000, Pages 685-686

Should tamoxifen be used to treat premenopausal women with breast cancer?

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PACLITAXEL; PROGESTERONE; TAMOXIFEN;

EID: 0033820004     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357900009032835     Document Type: Short Survey
Times cited : (4)

References (13)
  • 3
    • 0030787363 scopus 로고    scopus 로고
    • A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG Trial MA.I)
    • (1997) Br Cancer Res Treat , vol.44 , pp. 211-215
    • Sawka, C.A.1    Pritchard, K.I.2    Shelley, W.E.3
  • 4
    • 0030876075 scopus 로고    scopus 로고
    • An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer
    • (1997) Br Cancer Res Treat , vol.44 , pp. 201-210
    • Crump, M.1    Sawka, C.A.2    DeBoer, G.3
  • 5
    • 0032537396 scopus 로고    scopus 로고
    • Tamoxifen for early breast cancer: An overview of the randomized trials
    • (1998) Lancet , vol.351 , pp. 1451-1467
  • 6
    • 0032547564 scopus 로고    scopus 로고
    • Polychemotherapy for early breast cancer: An overview of the randomized trials
    • (1998) Lancet , vol.352 , pp. 930-942
  • 7
    • 0031927983 scopus 로고    scopus 로고
    • A randomized trial of cyclophosphamide, epirubicin, fluorouracil chemotherapy compared with cyclophosphamide, methrotrexate, fluorouracil in premenopausal women with node-positive breast cancer
    • (1998) J Clin Oncol , vol.16 , pp. 2651-2658
    • Levine, M.N.1    Bramwell, V.H.2    Pritchard, K.I.3
  • 8
    • 0001261990 scopus 로고    scopus 로고
    • Improved disease-free (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients (PTS) with node-positive primary breast cancer. For CALGB, ECOG, SWOG, and NCCTG
    • abstract
    • (1998) Proceedings of Amer Soc Clin Oncol , vol.17
    • Henderson, I.C.1    Berry, D.2    Demetri, G.3
  • 9
    • 0022623005 scopus 로고
    • Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5 Year results from the National Surgical Adjuvant Breast and Bowel Project Trial
    • (1986) J Clin Oncol , vol.4 , pp. 459-471
    • Fisher, B.1    Redmond, C.2    Brown, A.3
  • 11
    • 0007938169 scopus 로고    scopus 로고
    • Personal communication. International Breast Cancer Study Group (IBCSG) Trial XI
    • (1996)
    • Goldhirsch, A.1
  • 12
    • 0007935682 scopus 로고    scopus 로고
    • Personal communication. European Organization for Research and Treatment of Cancer (EORTC) Study
    • (1999)
    • Piccart, M.1
  • 13
    • 0007935469 scopus 로고    scopus 로고
    • Personal communication. National Cancer Institute of Canada Clinical Trials Group (NCIC CTG)
    • (1999)
    • Bramwell, V.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.